1. Volume 56, Issue 2, Pages 674-684 (August 1999)
Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure 
Luca De Nicola, Vincenzo Bellizzi, Roberto Minutolo, Michele Andreucci, Alfredo Capuano, Giacomo Garibotto, Gaetano Corso, Vittorio E. Andreucci, Bruno Cianciaruso 
Kidney International 
Volume 56, Issue 2, Pages (August 1999)
DOI: /j x
Copyright © 1999 International Society of Nephrology Terms and Conditions

2. Figure 1
Plasma levels of arginine (A), plasma nitrates (B), and urinary excretion of nitrates (C) in patients with moderate renal failure treated with arginine (solid line) or placebo (dotted line) at baseline and during follow-up. The gray area indicates the normal range attained from measurements in the normal group. *P < 0.05 vs. basal; •P < 0.05 vs. placebo group.
Kidney International  , DOI: ( /j x)
Copyright © 1999 International Society of Nephrology Terms and Conditions

3. Figure 2
Amino acid-induced change from baseline of glomerular filtration rate (GFR; ) and renal plasma flow () in normal subjects and in chronic renal failure patients treated with arginine (ARG) or placebo (Con) at baseline and after the six-month period of treatment. *P < 0.05 vs. other groups.
Kidney International  , DOI: ( /j x)
Copyright © 1999 International Society of Nephrology Terms and Conditions